Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S9 pseudogene 2 (RPS9P2) is a processed pseudogene located in the human genome. It shares sequence similarity with the ribosomal protein S9 (RPS9) gene but does not encode a functional protein product[7]. Pseudogenes such as RPS9P2 arise from gene duplication or retrotransposition events and lack the capacity to code for functional proteins due to mutations or truncations. RPS9P2 is referenced in genetic databases by alternative names such as bA12M9.1 and RPS9_3_1753[5][7]. There is no evidence supporting its involvement in therapeutic targeting, biological function, disease association, or any interaction with drugs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S9 pseudogene 2 (RPS9P2).